Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.
about
Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection.KASL clinical practice guidelines: management of chronic hepatitis BNon-invasive prediction of forthcoming cirrhosis-related complications.A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis BFibrosis assessment in patients with chronic hepatitis B virus (HBV) infection.Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis BA novel model to predict esophageal varices in patients with compensated cirrhosis using acoustic radiation force impulse elastographyNon invasive tools for the diagnosis of liver cirrhosis.Quantitative Measurement of Hepatic Fibrosis with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Chronic Hepatitis B Infection: A Comparative Study on Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index.Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis.Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression.Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis.The effectiveness of noninvasive biomarkers to predict hepatitis B-related significant fibrosis and cirrhosis: a systematic review and meta-analysis of diagnostic test accuracy.Is the neutrophil to lymphocyte ratio associated with liver fibrosis in patients with chronic hepatitis B?Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis BHIV and Hepatitis B Virus Coinfection: Approach to Management: Case Study and Commentary.Disorder-related risk factors for revision total hip arthroplasty after hip hemiarthroplasty in displaced femoral neck fracture patients: a nationwide population-based cohort studyNoninvasive assessment of liver damage in chronic hepatitis B.Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?Non-invasive assessment of liver fibrosis: it is time for laboratory medicine.Do we need a common liver fibrosis index or etiology-related indices?Dynamic Changes in Liver Stiffness Measured by Transient Elastography Predict Clinical Outcomes Among Patients With Chronic Hepatitis B.Noninvasive markers for staging fibrosis in chronic delta hepatitis.Stepwise Application of FIB-4, Red cell distribution width-Platelet Ratio and APRI for Compensated Hepatitis B Fibrosis Detection.Optimization of hepatitis B cirrhosis detection by stepwise application of transient elastography and routine biomarkers.Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B.Noninvasive predictive models of liver fibrosis in patients with chronic hepatitis B.Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study.Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test.Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis.A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection.Systemic abnormalities in liver disease.Reply to: Importance of Platelet Indices in Hepatocellular Carcinoma Prognosis.
P2860
Q26740195-4F8AA786-B1B8-4114-B557-1266A8D0AF77Q26752475-87198A55-0C49-4225-AF30-B6895ED0517DQ27000645-1DA76BDB-62FC-4788-9A89-558D0513FE91Q28741501-D0C30286-DCF4-4687-B08B-923755094609Q30362068-20330277-9D1B-45DD-9556-0DE43BF9E9CEQ30406744-1859A806-76A1-49EF-9E80-76CE159D2B39Q30414595-32CB276D-011F-42C9-889B-B3BB7B1B8C62Q30421450-D3582653-7D4D-4F59-BEAD-C3B6AAADAE11Q33561380-D48B62AD-0AE4-43C7-9766-99FC3565D737Q34158701-17548EA3-C2E4-43E1-9949-08EEE43B8A51Q34365464-FF83881C-2C8F-4B80-B5D0-6297ADCD8244Q34437952-4112E392-29D4-4C8C-A29B-DD0E324F2D2EQ35194722-CB5C4423-21D2-4C26-AEC9-076C70134FE2Q35594244-AA7EF442-02C2-4519-B704-52D41439FCBBQ35879457-DC507344-8408-4640-8BCB-9DEA1D0BF495Q36916860-89B7F51C-F236-42EA-BCA4-263D9AF2A947Q36980864-D7C54D4F-41A8-4F2D-B2DB-22037C325C25Q37157860-7FC2A3FE-4525-47B9-8400-C3CF580675A8Q37328464-7D9EEF04-19C8-4FA6-92EE-44A473EE5208Q37801658-AC4D95CB-5430-4FCD-884B-96146CBE601CQ39018751-BFFD387C-3B80-4C3D-8AB3-CC0A88800955Q39134237-DCEEEB5C-511F-45A3-986B-80B9BC19D0D3Q39215794-F456CFDB-8C23-4047-BEC7-2E8481D836E5Q40223838-F5299AD3-3327-4DA9-8E88-1194D1BCE48DQ40635899-634E1C0F-E125-4845-BD03-3EA7C9D30A52Q40707349-7DE035CF-4800-4ADB-A69B-524CBD434EC8Q41416623-FDBEBDDC-A8AB-4FA4-8C7B-C0328F5E7AAAQ42164803-81D2E044-56B0-4D13-A93D-1EA184F7025AQ42198890-6C5EFC72-ED2B-4E4A-ACC5-BDEE2C1B5A27Q42212445-3C52B1DC-45AF-4D79-80BE-D4132025525AQ42254850-444D8A19-4F30-40FA-83E8-A31C0138C0D4Q42623529-B258AB20-DFE8-4D9C-9155-8D52E512DA1EQ50075867-470DA4BF-8464-45C5-9D2C-BDD154563784
P2860
Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.
@en
type
label
Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.
@en
prefLabel
Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.
@en
P2093
P2860
P1433
P1476
Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B
@en
P2093
Beom Kyung Kim
Chae Yoon Chon
Hwa Sook Kim
Jae Youn Cheong
Jun Yong Park
Sung Ae Kim
Sung Won Cho
Young Myoung Moon
Young Nyun Park
P2860
P304
P356
10.1111/J.1478-3231.2007.01519.X
P577
2007-09-01T00:00:00Z